BDBM50338374 (S)-3-(methylsulfonylmethyl)-2-phenyl-N-(1-phenylpropyl)quinoline-4-carboxamide::CHEMBL1682944
SMILES: CC[C@H](NC(=O)c1c(CS(C)(=O)=O)c(nc2ccccc12)-c1ccccc1)c1ccccc1
InChI Key: InChIKey=GIUSAYWKRZPTAQ-QHCPKHFHSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM50338374 ((S)-3-(methylsulfonylmethyl)-2-phenyl-N-(1-phenylp...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a |
AstraZeneca Pharmaceuticals Curated by ChEMBL | Assay Description Antagonist activity at human NK3 receptor expressed in CHO cells assessed as inhibition of senktide-induced calcium flux by FLIPR assay | Bioorg Med Chem Lett 21: 1896-9 (2011) Article DOI: 10.1016/j.bmcl.2010.11.003 BindingDB Entry DOI: 10.7270/Q2XP7586 | |||||||||||
More data for this Ligand-Target Pair |